Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Real-world experience of semaglutide 2.4 mg in the US: a retrospective analysis of profiles, satisfaction, and treatment patterns in people with obesity and overweight
Current medical research and opinion, 2026;:1-12
Cardiovascular outcomes of semaglutide and tirzepatide in type 2 diabetes mellitus and obesity: a systematic review and meta-analysis
Diabetology & metabolic syndrome, 2026
Peptide Marriages: Modular Assembly of Multi-Agonist Therapeutics
Chemistry (Weinheim an der Bergstrasse, Germany), 2026;:e71280
Differential impact of pre-operative tirzepatide compared to glucagon-like-peptide-1 single receptor agonists on outcomes of spinal fusion surgery in obese patients
European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026
Semaglutide exerts anti-pulmonary fibrosis effects by inhibiting cellular senescence through activation of the Sirt1/HSF1/HSPs pathway
Biochemical pharmacology, 2026;:118172
Negative effects of semaglutide on bone in obese mice
Cell reports. Medicine, 2026;:102875
Association Between GLP-1RAs and Postoperative Complications Following Operative Ankle Fracture Fixation: A Retrospective Cohort Study
Foot & ankle orthopaedics, 2026;11(2):24730114261453350
Psychiatric Safety Signals of GLP-1 Receptor Agonists: A FAERS-Based Pharmacovigilance Study with Explainable Machine Learning
Pharmaceuticals (Basel, Switzerland), 2026;19(6)
Insulin Resistance as a Systemic Metabolic Risk State for Cancer: Mechanisms, Biomarkers, and Prevention
International journal of molecular sciences, 2026;27(12)
Long-Term Mechanical Complications After Lumbar Fusion in Patients Receiving Tirzepatide vs Other GLP-1 Receptor Agonists
Spine, 2026
Obstetrical and medical outcomes following GLP-1 receptor agonist exposure in pregnancy: a case series
Case reports in women's health, 2026;51:e00831
Micronutrient risk with GLP-1 receptor and dual incretin agonists in obesity: Mechanistic pathways, clinical signals, and a monitoring framework
Obesity pillars, 2026;19:100290
Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus: a network meta-analysis based on clinical trials
Frontiers in pharmacology, 2026;17:1846714
The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration
Frontiers in endocrinology, 2026;17:1822475
Weight-Lowering Drugs and Natural Female Fertility-A Systematic Review and Meta-Analysis
Clinical obesity;16(4):e70092
Pityriasis Lichenoides et Varioliformis Acuta Associated With Tirzepatide: A First Report
Journal of diabetes;18(6):e70233
Semaglutide and Risk of Adult-Onset Seizure: A Target Trial Emulation
Neurology, 2026;107(1):e218174
Selecting Pharmacologic Interventions for MASH
Digestive diseases and sciences, 2026
Pharmacotherapy for Children and Adolescents With Overweight or Obesity: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Diabetes, obesity & metabolism, 2026
A Computational Trial of Dermal Mechanotransduction in GLP-1 Receptor Agonist-Associated Premature Facial Ageing
Aesthetic plastic surgery, 2026